Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / ADS
-
Total 13F shares
-
18,859,920
-
Share change
-
-607,129
-
Total reported value
-
$2,280,843,376
-
Put/Call ratio
-
110%
-
Price per share
-
$120.94
-
Number of holders
-
174
-
Value change
-
-$70,694,859
-
Number of buys
-
97
-
Number of sells
-
60
Institutional Holders of GW PHARMACEUTICALS PLC - ADS (GWPH) as of Q1 2017
As of 31 Mar 2017,
GW PHARMACEUTICALS PLC - ADS (GWPH) was held by
174 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,859,920 shares.
The largest 10 holders included
Capital Research Global Investors, PRUDENTIAL PLC, SCOPIA CAPITAL MANAGEMENT LP, FMR LLC, Viking Global Investors LP, PRICE T ROWE ASSOCIATES INC /MD/, JANUS CAPITAL MANAGEMENT LLC, Capital World Investors, BANK OF AMERICA CORP /DE/, and ORBIMED ADVISORS LLC.
This page lists
174
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.